Blake Williams, ARNP

NPI: 1245624626
Total Payments
$5,938
2024 Payments
$5,435
Companies
7
Transactions
63
Medicare Patients
1,553
Medicare Billing
$131,570

Payment Breakdown by Category

Other$3,020 (50.9%)
Food & Beverage$1,472 (24.8%)
Travel$1,446 (24.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,020 2 50.9%
Food and Beverage $1,472 58 24.8%
Travel and Lodging $1,446 3 24.4%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $5,054 23 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $484.47 24 $0 (2024)
Madrigal Pharmaceuticals $153.87 2 $0 (2024)
ABBVIE INC. $123.03 7 $0 (2024)
Intercept Pharmaceuticals, Inc. $58.36 3 $0 (2024)
Ipsen Biopharmaceuticals, Inc $38.38 2 $0 (2024)
Echosens North America, Inc. $26.04 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,435 31 Gilead Sciences, Inc. ($4,930)
2023 $140.84 8 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($63.77)
2022 $191.83 13 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($137.78)
2021 $170.76 11 Gilead Sciences, Inc. ($64.84)

All Payment Transactions

63 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.13 General
Category: Gastroenterology
11/26/2024 Gilead Sciences, Inc. Livdelzi (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $980.00 General
Category: INFLAM
11/22/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $17.94 General
Category: Rare Disease
11/21/2024 Gilead Sciences, Inc. Livdelzi (Drug) Food and Beverage In-kind items and services $94.42 General
Category: INFLAM
11/21/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $28.97 General
Category: LIVER DISEASE
11/12/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $121.34 General
Category: Gastroenterology
10/28/2024 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $24.60 General
Category: Hepatology / Gastroenterology
10/24/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $22.14 General
10/09/2024 Gilead Sciences, Inc. Livdelzi (Drug) Food and Beverage In-kind items and services $74.52 General
Category: INFLAM
10/09/2024 Gilead Sciences, Inc. Livdelzi (Drug) Food and Beverage In-kind items and services $46.21 General
Category: INFLAM
10/09/2024 Gilead Sciences, Inc. Livdelzi (Drug) Food and Beverage In-kind items and services $8.48 General
Category: INFLAM
10/09/2024 Gilead Sciences, Inc. Livdelzi (Drug) Food and Beverage In-kind items and services $4.15 General
Category: INFLAM
09/25/2024 Gilead Sciences, Inc. Livdelzi (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,040.00 General
Category: INFLAM
09/23/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $124.90 General
Category: LIVER DISEASE
08/28/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.86 General
Category: Gastroenterology
08/24/2024 Gilead Sciences, Inc. Livdelzi (Drug) Travel and Lodging In-kind items and services $742.95 General
Category: INFLAM
08/24/2024 Gilead Sciences, Inc. Livdelzi (Drug) Travel and Lodging In-kind items and services $449.50 General
Category: INFLAM
08/24/2024 Gilead Sciences, Inc. Livdelzi (Drug) Travel and Lodging In-kind items and services $253.49 General
Category: INFLAM
08/24/2024 Gilead Sciences, Inc. Livdelzi (Drug) Food and Beverage In-kind items and services $59.36 General
Category: INFLAM
08/24/2024 Gilead Sciences, Inc. Livdelzi (Drug) Food and Beverage In-kind items and services $55.55 General
Category: INFLAM
08/24/2024 Gilead Sciences, Inc. Livdelzi (Drug) Food and Beverage In-kind items and services $52.20 General
Category: INFLAM
08/24/2024 Gilead Sciences, Inc. Livdelzi (Drug) Food and Beverage In-kind items and services $36.84 General
Category: INFLAM
08/05/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.03 General
Category: Gastroenterology
07/03/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.56 General
Category: Gastroenterology
04/23/2024 Ipsen Biopharmaceuticals, Inc Food and Beverage In-kind items and services $20.44 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 442 565 $125,644 $35,276
2022 6 459 575 $126,277 $37,785
2021 5 360 472 $99,966 $33,552
2020 7 292 359 $87,766 $24,956
Total Patients
1,553
Total Services
1,971
Medicare Billing
$131,570
Procedure Codes
25

All Medicare Procedures & Services

25 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 227 334 $80,983 $23,250 28.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 21 28 $9,502 $2,930 30.8%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 20 20 $8,695 $2,619 30.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 34 34 $11,331 $2,546 22.5%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 32 39 $6,699 $1,874 28.0%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2023 22 24 $5,843 $1,623 27.8%
91200 Measurement of liver stiffness Facility 2023 86 86 $2,591 $434.20 16.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 253 360 $87,838 $26,015 29.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 43 43 $13,588 $4,040 29.7%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 44 48 $11,712 $3,568 30.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 16 17 $5,831 $1,948 33.4%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 28 31 $5,332 $1,728 32.4%
91200 Measurement of liver stiffness Facility 2022 75 76 $1,976 $486.74 24.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 239 346 $78,888 $26,458 33.5%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 39 39 $11,427 $3,863 33.8%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 23 27 $3,826 $1,470 38.4%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 11 11 $4,257 $1,451 34.1%
91200 Measuring the stiffness in the liver via elastography Facility 2021 48 49 $1,568 $310.89 19.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 132 174 $36,018 $10,111 28.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 27 27 $13,122 $3,536 27.0%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 47 53 $10,971 $3,506 32.0%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 29 48 $12,000 $3,182 26.5%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 24 24 $7,488 $2,152 28.7%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 14 14 $5,488 $1,602 29.2%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 19 19 $2,679 $867.18 32.4%

About Blake Williams, ARNP

Blake Williams, ARNP is a Family healthcare provider based in Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1245624626.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Blake Williams, ARNP has received a total of $5,938 in payments from pharmaceutical and medical device companies, with $5,435 received in 2024. These payments were reported across 63 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3,020).

As a Medicare-enrolled provider, Williams has provided services to 1,553 Medicare beneficiaries, totaling 1,971 services with total Medicare billing of $131,570. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Other Specialties Nurse Practitioner
  • Location Des Moines, IA
  • Active Since 03/24/2015
  • Last Updated 03/07/2023
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1245624626

Products in Payments

  • Livdelzi (Drug) $4,898
  • XIFAXAN (Drug) $484.47
  • RESMETIROM (Drug) $153.87
  • MAVYRET (Drug) $123.03
  • OCALIVA (Drug) $58.36
  • FibroScan (Device) $26.04
  • IQIRVO (Drug) $17.94
  • Epclusa (Drug) $13.90

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Des Moines